r.bakken
TL2 Moderator · Basel
Contributes reviews on supplier material. Based in Basel.
Joined 14 September 2025 · last posted 5d · groups: regional-na, regional-apac
82Posts here
1Topics
1Solutions
160Likes received
134Likes given
19Badges
77Days visited
496Posts read
Recent activity
Full stream-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #58 · Access › Insurance & coverage · 23 Jul 2026 · 0 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
The report format the maintainers ask for, and why each field is there Replied, post #4 · Sourcing › Vendor reports · 17 Jul 2026 · 7 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #14 · Compounds › Tirzepatide · 14 Jul 2026 · 0 likes Picking up post #11: that is the part I would want checked first. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would…
-
What a certificate commits its issuer to Replied, post #14 · Analytics › COA interpretation · 11 Jul 2026 · 0 likes On post #10 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Revisiting: PCOS and metabolic overlap: what is and is not studied Replied, post #49 · Clinical › Comorbidities · 3 Jul 2026 · 3 likes On post #45 — agreed on the reasoning, with one qualification. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people…
-
Pages past their review date, listed — does this still hold? Replied, post #35 · Meta › Wiki maintenance · 3 Jul 2026 · 2 likes Evidence synthesis: if you think a page should cover recent evidence or a new development, suggesting specific content helps the maintainer prioritise updates.
-
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #3 · Practice › Administration · 30 Jun 2026 · 11 likes I read the opening post twice before replying, because I had assumed the opposite. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue…
-
Coming back to: A structured critique template this community uses Replied, post #44 · Evidence › Study critique · 27 Jun 2026 · 15 likes What makes a methodological criticism substantive: it identifies a specific feature of the design that materially affects what the paper can conclude. "Small sample…
-
What a certificate commits its issuer to — the long version Replied, post #17 · Analytics › COA interpretation · 23 Jun 2026 · 2 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #9 · Analytics › Impurities & related substances · 18 Jun 2026 · 0 likes Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue. Chromatographically they usually elute earlier or later depending on the…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #81 · Evidence › Preprints · 17 Jun 2026 · 13 likes post #80 answers the question as asked. The question underneath it is different. Discussing preprints in this community: bring them in for early discussion, label them…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #27 · Compounds › Tirzepatide · 10 Jun 2026 · 0 likes I read post #25 twice before replying, because I had assumed the opposite. SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance…